EC Clinical and Medical Case Reports

Case Report Volume 6 Issue 4 - 2023

Drug-Induced Liver Injury from Vismodegib: A Case Report

Zehra Irshad*, Hina Shahid and Nwe Ni Than

Academic Clinical Fellow University Hospital Coventry and Warwickshire

*Corresponding Author: Zehra Irshad, Academic Clinical Fellow University Hospital Coventry and Warwickshire.
Received: March 16, 2023; Published: March 28, 2023




Vismodegib is a hedgehog pathway inhibitor; commonly used in patients with advanced basal cell carcinoma. Hepatotoxicity or drug induced liver injury (DILI) from vismodegib had been reported in literature but still regarded as a rare event. We reported a case of a patient presented with biopsy proven DILI that occurred two weeks after starting vismodegib.

Keywords: Drug-Induced Liver Injury; Jaundice; Hepatotoxicity; Vismodegib

Zehra Irshad., et al. "Drug-Induced Liver Injury from Vismodegib: A Case Report." EC Clinical and Medical Case Reports   6.4 (2023): 142-145.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net